Parker Albert P

CIK 00017500792 companiesALAMEDA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001750079

Recent Transactions

16 trades

Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−33,685→ 193,333 total
Disposition to Issuer
Zynerba Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-10-10−200,000→ 0 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10+85,000→ 278,333 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−278,333→ 0 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-15$0.54/sh−3,173→ 227,018 total
Tax Payment
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-08$0.60/sh−5,463→ 230,191 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-07+18,864→ 235,654 total
Tax Payment
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-01$0.60/sh−5,841→ 216,790 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-31+17,631→ 222,631 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-24+170,000→ 205,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-02-14+200,000→ 200,000 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-02-14+35,000→ 35,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2020-12-11+5,586→ 10,586 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-08-03$1.33/sh+5,000→ 5,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to purchase common stock
2020-02-10+204,000→ 204,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2019-03-14+200,000→ 200,000 total

Companies

Recent Filings

Address

C/O ONCOCYTE CORPORATION 1010 ATLANTIC AVENUE, SUITE 102

ALAMEDA, CA, 94501

View on SEC.gov